Sickle cell patients have begun receiving the first new treatment for the blood disorder in over 20 years.
The inherited condition can cause severe pain and organ failure, often requiring hospital admissions.
Crizanlizumab is given as a monthly infusion and is thought to cut visits to A&E by 40%. Loury Mooruth, 62, received the treatment at Birmingham City Hospital, having suffered repeated periods of intense pain for decades.
During a crisis, patients often need powerful opioid painkillers but Loury, like many others, has faced suspicion when at A&E.
"You know the